MUMBAI: The majority of the country’s sickest patients may no longer benefit from carbapenem, an antibiotic that effectively treated pneumonia and septicemia until a decade back, according to the latest Indian Council of Medical Research (ICMR) study on antimicrobial resistance.The study, released on Friday, found that abuse of antimicrobials — be they antibiotics, antivirals or antifungals — had...